Allergy & Immunology Doctors in Memphis, TN Accepting Medicare

8 Allergy & Immunology doctors found. Showing 1 - 8

Dr. Joe S Levy, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 5575 Poplar Ave, Memphis, TN 38119 Phone: 901-682-0430    Fax: 901-680-0363

Amy Elizabeth Ragsdale, D.O. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 6401 Poplar Ave Ste 300, Memphis, TN 38119 Phone: 901-757-6100    Fax: 855-656-7325

Dr. Richard G Wanderman, MD Allergy & Immunology - Allergy Medicare: Medicare Enrolled Practice Location: 4646 Poplar Ave Ste 302, Memphis, TN 38117 Phone: 901-930-7397    Fax: 905-552-3902

Venusa Phomakay, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 6401 Poplar Ave Ste 300, Memphis, TN 38119 Phone: 901-757-6100

Phillip L Lieberman, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 6401 Poplar Ave Ste 300, Memphis, TN 38119 Phone: 901-757-6100    Fax: 855-656-7325

Terrye Mastin, APRN,BC Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 5625 Poplar Ave, Memphis, TN 38119 Phone: 901-761-1220    Fax: 901-763-4332

Brandon Hill, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1030 Jefferson Ave, Memphis, TN 38104 Phone: 901-523-8990

Dr. Steve Cole, M.D. Allergy & Immunology - Allergy Medicare: Accepting Medicare Assignments Practice Location: 1750 Madison Ave Ste 210, Memphis, TN 38104 Phone: 901-726-4055    Fax: 901-726-4887

News Archive

Positive clinical trial results for Anacor Pharmaceuticals' AN2728 announced

Anacor Pharmaceuticals today announced positive clinical trial results for its lead phosphodiesterase-4 inhibitor, AN2728, a novel topical anti-inflammatory compound derived from Anacor's boron chemistry platform. These results were obtained from a multi-center, Phase 2b, randomized, double-blind, dose-ranging, bilateral trial comparing AN2728 ointment, 0.5% and 2.0%, applied once or twice daily, to vehicle in 145 patients with mild-to-moderate plaque-type psoriasis.

BIO-key International awards contract for fingerprint biometric identity solution

BIO-key International, Inc., a leader in finger-based biometric identification solutions announced the award of another contract for a fingerprint biometric identity solution built on the fusion of BIO-key and MorphoTrak algorithms. The first contract for this fused solution, awarded to MorphoTrak (a Morpho company) by Lockheed Martin in September 2009, provides fingerprint identification technology for the FBI's Next Generation Identification (NGI) system. This new contract will provide large scale advanced finger matching technology to an overseas customer.

Graphene-based nanoplatforms for synergistic tumor therapy and bio-imaging

In a paper to be published in the forthcoming issue in NANO, researchers from Harbin Institute of Technology, China have systematically discussed the recent progresses, current challenges and future perspectives of smart graphene-based nanoplatforms for synergistic tumor therapy and bio-imaging.

CDC warns on lung diseases linked to vaping

Vaping or using e-cigarettes has gained immense population over the past few years. It's widely regarded as a healthier alternative to cigarette smoking. Now, health officials warn against vaping as the Centers for Disease Control and Prevention (CDC) says that a cluster of lung diseases associated with e-cigarette use was reported in 14 states.

Read more Medical News

› Verified 6 days ago